N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). (Q44011659)
Jump to navigation
Jump to search
scientific article published on 3 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). |
scientific article published on 3 April 2013 |
Statements
1 reference
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). (English)
1 reference
1 reference
Christopher B Granger
1 reference
Lars Wallentin
1 reference
Agneta Siegbahn
1 reference
Bernard J Gersh
1 reference
Renato D Lopes
1 reference
Stefan Hohnloser
1 reference
John J V McMurray
1 reference
John Horowitz
1 reference
Ziad Hijazi
1 reference
Christina Christersson
1 reference
Michael Hanna
1 reference
Ulrika Andersson
1 reference
Kurt Huber
1 reference
3 April 2013
1 reference
1 reference
Identifiers
1 reference